Bioheart Makes Breakthrough In Critical Limb Ischemia Therapy With Stem Cells Obtained From Fat Tissue
Bioheart, Inc. (OTC Bulletin Board: BHRT) offers yet another medical breakthrough with the next-level stem cell treatment for critical limb ischemia patients. The stem cells aid in promoting angiogenesis or the formation of new blood vessels and providing support for the healing of damaged blood vessels…
[Read the full article here]Related News:
Bioheart makes breakthrough in stem cell treatment for critical limb ischemia
Bioheart Makes Breakthrough in Cardiovascular Therapy with Stem Cells …
Stem cell treatment candidate for Critical Limb Ischemia fueling Aastrom Biosciences